Navigation Links
Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
Date:10/23/2007

3.0% 4.1% 2.0% 6.9%

Business Unit Sales

(in millions)

First Second Third Fourth

Quarter Quarter Quarter Quarter Total

2006 2006 2006 2006 2006

Research Essentials $91.8 $88.1 $87.4 $88.0 $355.3

Research Specialties 168.8 164.1 164.2 172.6 669.7

Research Biotech 71.8 69.0 65.4 70.6 276.8

SAFC 110.7 127.3 124.4 133.3 495.7

Total Customer Sales $443.1 $448.5 $441.4 $464.5 $1,797.5

First Second Third

Quarter Quarter Quarter

2007 2007 2007 YTD 2007

Research Essentials $98.8 $95.9 $94.9 $289.6

Research Specialties 189.3 185.6 186.6 561.5

Research Biotech 75.2 72.8 72.7 220.7

SAFC 132.6 153.2 149.0 434.8

Total Customer Sales $495.9 $507.5 $503.2 $1,506.6

SIGMA-ALDRICH CORPORATION

Supplemental Financial Information - (Unaudited)

Reconciliation of Proforma to Reported Net Income

Net Income Diluted Earnings

(in millions) Per Share

Three Months Three Months

Ended Ended

September 30, September 30,

2007 2006 2007 2006

Proforma net income before currency

impact $63.4 $68.4 $0
'/>"/>

SOURCE Sigma-Aldrich
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Jellyfish partners for sales tracking technology
2. Doyle wants sales tax applied to digital downloads
3. Mortgagebot builds online sales even as housing declines
4. Third Wave reports another loss, stronger sales
5. Johnson Controls reports record quarterly sales
6. Can sales outsourcing grow Wisconsin biotechs?
7. Sonic Foundry reports quarterly loss, higher Mediasite sales
8. My-oh, its BIO! Where sales hype and science collide
9. Third Wave shuffles finance, sales management
10. Johnson Controls sales up, profits down
11. Turning ads into sales: Context is king
Post Your Comments:
*Name:
*Comment:
*Email: